GlassScriptPhysician profile
Paul S Davis
NPI 1265457659
$12,429.58
in general payments reported to CMS, 2019-2025
40 companies · $2,575 in 2025
The $2,575 reported for 2025 was more than what 92% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,297 · 2020: $2,365 · 2021: $1,568 · 2022: $1,367 · 2023: $879 · 2024: $1,379 · 2025: $2,575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,812 · Long Term Medical Supply Or Device Loan: $1,000 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,812.49 |
| Long Term Medical Supply Or Device Loan | $1,000.00 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,447.45 | 2019-2025 | General - Atherectomy, General - Therapies, Jetstream Sc |
| E.R. Squibb & Sons, L.L.C. | $1,765.91 | 2019-2025 | Eliquis |
| Bard Peripheral Vascular, INC. | $1,214.31 | 2020-2022 | |
| Angiodynamics, INC. | $1,134.52 | 2023-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Janssen Pharmaceuticals, INC | $1,009.88 | 2019-2022 | |
| Smith+Nephew, INC. | $668.23 | 2019-2025 | Pico, Renasys Touch, Renasys Go V2 Home |
| Medtronic Vascular, INC. | $447.26 | 2019-2020 | |
| Hitachi Healthcare Americas Corp. | $426.44 | 2019-2020 | |
| Medtronic, INC. | $407.56 | 2021-2025 | Closurefast, Venaseal |
| Paratek Pharmaceuticals, INC. | $368.77 | 2021-2025 | Nuzyra |
| Csl Behring | $341.14 | 2019-2024 | Kcentra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $246.52 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $245.97 | 2024 | Airsupra, Farxiga |
| Pfizer INC. | $189.62 | 2021-2025 | |
| Tactile Systems Technology INC | $147.44 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $127.99 | 2020-2023 | |
| Novo Nordisk INC | $124.98 | 2025 | Ozempic |
| Ars Pharmaceuticals Operations, INC. | $124.96 | 2025 | Neffy |
| Avinger INC. | $100.19 | 2020 | |
| Melinta Therapeutics, LLC | $88.65 | 2019 | |
| Organogenesis INC. | $83.84 | 2020-2023 | Puraply |
| Solventum Corporation | $83.56 | 2025 | Prevena, V.A.C.Ulta, Activ.A.C. |
| W. L. Gore & Associates, INC. | $82.43 | 2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Inari Medical, INC. | $68.44 | 2020 | |
| Merck Sharp & Dohme LLC | $59.27 | 2019 | |
| Reprise Biomedical, INC. | $55.79 | 2023-2025 | Miro3d, Miroderm |
| Cook Medical LLC | $50.23 | 2019-2024 | Zilver Ptx |
| Lemaitre Vascular, INC. | $50.00 | 2019-2024 | Artegraft Vascular Graft |
| Terumo Medical Corporation | $44.70 | 2025 | Glidesheath Slender, Angio-Seal, Azur Cx Detachable |
| Acelrx Pharmaceuticals, INC. | $26.15 | 2022 | |
| Abbott Laboratories | $25.87 | 2022 | |
| Kci USA, INC. | $24.36 | 2021 | |
| Janssen Biotech, INC. | $22.32 | 2025 | Tremfya |
| Ekos Corporation | $19.40 | 2019 | |
| Biocompatibles, INC. | $19.05 | 2019 | |
| Urgo Medical North America, LLC | $18.99 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Mimedx Group, INC. | $18.61 | 2025 | |
| Siemens Medical Solutions USA, INC. | $17.80 | 2019 | |
| Shockwave Medical, INC | $17.35 | 2020 | |
| Venturemed Group, INC. | $13.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.